At LOG Pharma Primary Packaging, we view every gathering with partners and peers as an opportunity to learn, collaborate, and shape the future of pharma packaging. Over the past weeks, we have had the privilege of participating in two important events that highlighted both the regional and global directions our industry is moving toward.
In Warsaw, we were delighted to join the Customer Academy Warsaw 2025, hosted by Constantia Flexibles and Perlen Packaging. LOG was represented by Efrat Kat, VP Sales & Business Development, and Attila Békési, International Sales Manager Europe. The event brought together leading voices from across the pharma value chain, creating a platform for engaging discussions around the evolving challenges of primary packaging.
Central to these conversations were the new European guidelines shaping our industry. As regulatory demands grow, so does the need for packaging that not only safeguards medicines but also aligns with sustainability goals. LOG had the opportunity to present our eco barrier bottles – the newest addition to our barrier packaging line. These bottles deliver a unique balance of enhanced protection, performance, and cost-effectiveness, while also offering an eco-friendly alternative for companies seeking to lower their environmental impact.
Meanwhile, across the Atlantic, our team to steps to further expand LOG’s presence in the U.S. market. Together with our colleagues from Perlen Packaging U.S., we met with existing customers to refine our go-to-market strategy and advance plans for local bottle manufacturing at Perlen’s New Jersey facility. Establishing local production will play a vital role in ensuring reliable supply while addressing the growing demand for innovative barrier packaging solutions.
Our participation in the Contract Pharma exhibition, which took place on September 19-20 2025 in New Jersey, further reinforced these insights. Conversations with leading CDMOs and CMOs highlighted a strong, shared recognition of the importance of protecting moisture- and oxygen-sensitive pharmaceuticals with advanced barrier technologies. This alignment confirms what we believe strongly in LOG: the market is ready for solutions that combine performance with sustainability.
These two events reflect LOG’s vision: driving innovation, strengthening partnerships, and building sustainable solutions for the pharma industry.
